IBDEI0A9 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4770,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,4771,0)
 ;;=691.8^^39^364^5
 ;;^UTILITY(U,$J,358.3,4771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4771,1,2,0)
 ;;=2^691.8
 ;;^UTILITY(U,$J,358.3,4771,1,5,0)
 ;;=5^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,4771,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,4772,0)
 ;;=692.9^^39^364^8
 ;;^UTILITY(U,$J,358.3,4772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4772,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4772,1,5,0)
 ;;=5^Xerotic Eczema
 ;;^UTILITY(U,$J,358.3,4772,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4773,0)
 ;;=686.8^^39^364^6
 ;;^UTILITY(U,$J,358.3,4773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4773,1,2,0)
 ;;=2^686.8
 ;;^UTILITY(U,$J,358.3,4773,1,5,0)
 ;;=5^Pustular Eczema
 ;;^UTILITY(U,$J,358.3,4773,2)
 ;;=^88097
 ;;^UTILITY(U,$J,358.3,4774,0)
 ;;=690.18^^39^364^7
 ;;^UTILITY(U,$J,358.3,4774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4774,1,2,0)
 ;;=2^690.18
 ;;^UTILITY(U,$J,358.3,4774,1,5,0)
 ;;=5^Seborrheic Eczema
 ;;^UTILITY(U,$J,358.3,4774,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,4775,0)
 ;;=705.81^^39^364^3
 ;;^UTILITY(U,$J,358.3,4775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4775,1,2,0)
 ;;=2^705.81
 ;;^UTILITY(U,$J,358.3,4775,1,5,0)
 ;;=5^Dyshidrotic Eczema/Pompholyx
 ;;^UTILITY(U,$J,358.3,4775,2)
 ;;=Dyshidrotic Eczema/Pompholyx^96545
 ;;^UTILITY(U,$J,358.3,4776,0)
 ;;=692.9^^39^364^2
 ;;^UTILITY(U,$J,358.3,4776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4776,1,2,0)
 ;;=2^692.9
 ;;^UTILITY(U,$J,358.3,4776,1,5,0)
 ;;=5^Atopic Eczema
 ;;^UTILITY(U,$J,358.3,4776,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,4777,0)
 ;;=274.89^^39^364^4
 ;;^UTILITY(U,$J,358.3,4777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4777,1,2,0)
 ;;=2^274.89
 ;;^UTILITY(U,$J,358.3,4777,1,5,0)
 ;;=5^Gouty Eczema
 ;;^UTILITY(U,$J,358.3,4777,2)
 ;;=^267936
 ;;^UTILITY(U,$J,358.3,4778,0)
 ;;=782.3^^39^365^3
 ;;^UTILITY(U,$J,358.3,4778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4778,1,2,0)
 ;;=2^782.3
 ;;^UTILITY(U,$J,358.3,4778,1,5,0)
 ;;=5^Pitting Edema
 ;;^UTILITY(U,$J,358.3,4778,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,4779,0)
 ;;=459.2^^39^365^2
 ;;^UTILITY(U,$J,358.3,4779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4779,1,2,0)
 ;;=2^459.2
 ;;^UTILITY(U,$J,358.3,4779,1,5,0)
 ;;=5^Edema d/t Venous Obstruction
 ;;^UTILITY(U,$J,358.3,4779,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,4780,0)
 ;;=457.1^^39^365^1
 ;;^UTILITY(U,$J,358.3,4780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4780,1,2,0)
 ;;=2^457.1
 ;;^UTILITY(U,$J,358.3,4780,1,5,0)
 ;;=5^Edema d/t Lymphatic Obstruction
 ;;^UTILITY(U,$J,358.3,4780,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,4781,0)
 ;;=695.2^^39^366^2
 ;;^UTILITY(U,$J,358.3,4781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4781,1,2,0)
 ;;=2^695.2
 ;;^UTILITY(U,$J,358.3,4781,1,5,0)
 ;;=5^Erythema Nodosum
 ;;^UTILITY(U,$J,358.3,4781,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,4782,0)
 ;;=692.71^^39^366^3
 ;;^UTILITY(U,$J,358.3,4782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4782,1,2,0)
 ;;=2^692.71
 ;;^UTILITY(U,$J,358.3,4782,1,5,0)
 ;;=5^Erythema Solara
 ;;^UTILITY(U,$J,358.3,4782,2)
 ;;=^115798
 ;;^UTILITY(U,$J,358.3,4783,0)
 ;;=695.0^^39^366^4
 ;;^UTILITY(U,$J,358.3,4783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4783,1,2,0)
 ;;=2^695.0
 ;;^UTILITY(U,$J,358.3,4783,1,5,0)
 ;;=5^Erythema Toxic
 ;;^UTILITY(U,$J,358.3,4783,2)
 ;;=^265514
 ;;^UTILITY(U,$J,358.3,4784,0)
 ;;=695.10^^39^366^1
 ;;^UTILITY(U,$J,358.3,4784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4784,1,2,0)
 ;;=2^695.10
 ;;^UTILITY(U,$J,358.3,4784,1,5,0)
 ;;=5^Erythema Multiforme NOS
 ;;^UTILITY(U,$J,358.3,4784,2)
 ;;=^336759
